OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

MGNX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

MacroGenics (MGNX) Earnings Date & Reports

Macrogenics Inc is a biotechnology company focused on discovering and developing antibody-based therapeutics for the treatment of cancer... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

MGNX is expected to report earnings to fall 5.71% to -61 cents per share on August 12

Q2'25

Est.

$-0.61

Q1'25

Est.

$-0.65

Q4'24

Beat

by $0.16

Q3'24

Beat

by $0.69

Q2'24

Missed

by $0.23

The last earnings report on May 13 showed earnings per share of -64 cents, meeting the estimate of -64 cents. With 9.54M shares outstanding, the current market capitalization sits at 75.08M.

View a ticker or compare two or three

Compare

MGNX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For MGNX
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a company, which engages in the discovery and development of monoclonal antibody-based therapeutics

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

9704 Medical Center Drive

Phone

+1 301 251-5172

Employees

339

Web

https://www.macrogenics.com